This medication is taken by injection.
Extavia® and Betaseron® are brand names for interferon beta 1b, a medication manufactured by a biotechnological process from one of the naturally occurring interferons (a type of protein).
Extavia and Betaseron are approved by the FDA for the treatment of relapsing forms of MS to reduce the frequency of clinical exacerbations. Relapsing forms of MS include individuals with secondary-progressive MS who continue to experience relapses or acute attacks. Betaseron iand Extavia are also approved for use in individuals who have experienced a first clinical episode (clinically-isolated syndrome) and have MRI features that are consistent with multiple sclerosis.
Click here to read the Extavia Prescribing Information for healthcare professionals.
Click here to read the Extavia Medication Guide for patients.
Click here to read the Betaseron Prescribing Information for healthcare professionals.
Click here to read the Betaseron Medication Guide for patients.
Extavia Go Program
Financial Assistance Program
EXTAVIA GO PROGRAM